Synthetic Cannabinoid Leading to Cannabinoid Hyperemesis Syndrome
نویسندگان
چکیده
منابع مشابه
Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome.
To the Editor: In their editorial on opiate overdose, Berge and Burkle list the release of new opioid drugs, the aggressive marketing to physicians, the declaration of pain as “the fifth vital sign,” and the increased willingness of physicians to treat noncancer pain with opioids as the measures that led to the explosion of sales of prescription opioid pain relievers. It is imperative that 3 ot...
متن کاملCannabinoid hyperemesis syndrome.
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent vomiting associated with abdominal pain. Routine treatment of the nausea and vomiting, associated with the chronic marijuana abuse, with antiemetics i...
متن کاملCannabinoid hyperemesis syndrome.
Introduction Marijuana is used in the United States and worldwide. It sometimes is used by patients, most generally illegally, for its antiemetic properties. Paradoxically, it actually can cause nausea and vomiting with abdominal pain in some patients. In recent years, there has been recognition of a new clinical condition known as Cannabinoid Hyperemesis Syndrome (CHS). This syndrome was first...
متن کاملCannabinoid hyperemesis syndrome with extreme hydrophilia
Marijuana is the most widely used recreational drug in the US. Hyperemetic hydrophilic syndrome is a previously described but infrequently recognized condition of cannabinoid abuse with hyperemesis and obsessive hot showering. We present a 47-year-old male known marijuana addict with intractable abdominal pain who could not wait for physical examination, meal, or medication, because of obsessiv...
متن کاملA Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid
Cannabinoid Hyperemesis Syndrome (CHS) was first described in 2004. Due to its novelty, CHS is often unrecognized by clinicians leading to expensive workup of these patients with cyclical symptoms. It may take up to 9 years to diagnose CHS. CHS is characterized by cyclical nausea and vomiting, abdominal pain, and an unusual compulsion to take hot showers in the presence of chronic use of cannab...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Mayo Clinic Proceedings
سال: 2014
ISSN: 0025-6196
DOI: 10.1016/j.mayocp.2014.06.013